Showing results (1521-1530 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trialElia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
The Lancet. Neurology|May 25, 2010
Vitamin D and multiple sclerosisAlberto Ascherio, Kassandra L Munger, K Claire Simon
The Lancet. Neurology|October 5, 2010
Treatment of small vessel primary CNS vasculitis in children: an open-label cohort studyClare Hutchinson, Jorina Elbers, William Halliday, et al.
The Lancet. Neurology|July 9, 2010
Multiple sclerosis: risk factors, prodromes, and potential causal pathwaysSreeram V Ramagopalan, Ruth Dobson, Ute C Meier, et al.
The Lancet. Neurology|July 24, 2010
Emerging effects of comorbidities on multiple sclerosisRuth Ann Marrie, Ralph I Horwitz
The Lancet. Neurology|August 14, 2010
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomasFrederic G Dhermain, Peter Hau, Heinrich Lanfermann, et al.
The Lancet. Neurology|August 31, 2010
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association studyAleksey Shatunov, Kin Mok, Stephen Newhouse, et al.
The Lancet. Neurology|August 31, 2010
Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association studyHannu Laaksovirta, Terhi Peuralinna, Jennifer C Schymick, et al.
The Lancet. Neurology|July 30, 2010
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTRNiaz Ahmed, Nils Wahlgren, Martin Grond, et al.
The Lancet. Neurology|February 15, 2011
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort studyBrit Mollenhauer, Joseph J Locascio, Walter Schulz-Schaeffer, et al.
Pageof 200